Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boehm

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Annals of Biomedical Engineering|April 10, 2019
Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered MyobundlesBrittany N J Davis, Jeffrey W Santoso, Michaela J Walker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2006
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancerJoanne L Blum, E Claire Dees, Aparna Chacko, et al.
Annals of Surgery|October 8, 2013
Improving ATLS performance in simulated pediatric trauma resuscitation using a checklistSamantha E Parsons, Elizabeth A Carter, Lauren J Waterhouse, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Blood|December 8, 2009
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaNicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, et al.
Human Molecular Genetics|March 19, 2004
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiencyAndreas Schmidt, Bart Marescau, Ernest A Boehm, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 30, 2017
Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossificationBenjamin M Wheatley, Katherine E Cilwa, Devaveena Dey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disordersPatrick H Roseboom, Sascha A L Mueller, Jonathan A Oler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Clinical Genitourinary Cancer|February 21, 2012
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancerMark T Fleming, Guru Sonpavde, Michael Kolodziej, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Annals of Biomedical Engineering|April 10, 2019
Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered MyobundlesBrittany N J Davis, Jeffrey W Santoso, Michaela J Walker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2006
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancerJoanne L Blum, E Claire Dees, Aparna Chacko, et al.
Annals of Surgery|October 8, 2013
Improving ATLS performance in simulated pediatric trauma resuscitation using a checklistSamantha E Parsons, Elizabeth A Carter, Lauren J Waterhouse, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Blood|December 8, 2009
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaNicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, et al.
Human Molecular Genetics|March 19, 2004
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiencyAndreas Schmidt, Bart Marescau, Ernest A Boehm, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 30, 2017
Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossificationBenjamin M Wheatley, Katherine E Cilwa, Devaveena Dey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disordersPatrick H Roseboom, Sascha A L Mueller, Jonathan A Oler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Clinical Genitourinary Cancer|February 21, 2012
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancerMark T Fleming, Guru Sonpavde, Michael Kolodziej, et al.
Pageof 21